AstraZeneca vaccine can be up to 90% effective; COVID-19 reinfection unlikely for at least six months


  • World
  • Tuesday, 24 Nov 2020

FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic

(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

AstraZeneca COVID-19 vaccine shows up to 90% efficacy

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

U.S. stocks close lower
Czech Republic records over 10,000 whooping cough cases this year
Roundup: U.S. witnesses bird flu outbreaks in poultry, dairy cows
US and allies aim to help Ukraine bolster defenses after aid gap
5 Tunisian fishermen dead after boat sank off eastern coast
Crude futures settle higher
Cargo ship fire in Dardanelles Strait halts maritime traffic
Feature: Students in UK wowed by time-honored cultural treasures of China
2 foreign tourists killed in road accident in Namibia
U.S. dollar ticks down

Others Also Read